News

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
Dr. Levi and Vicky Pebsworth, a nurse affiliated with an anti-vaccine group, voted against recommending clesrovimab; the ...
New research uses bird droppings to track avian flu in remote regions, revealing hidden hotspots and potential for early ...